Aligos Therapeutics Inc
Biotechnology
Healthcare
ALGS
8.71 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
9.57
52 week high
45.62
high
10.50
52 week low
0.00
previous Close
9.53
P/E ratio
-7
market cap
49.16 M
div yield
0
net incoming
-15.86 M
-136.82 %
net profit margin
-1643.83 %
-15498.00 %
operating incoming
-18.57 M
3.51 %
net change in cash
-55.10 M
-249.87 %
cash on hand
18.66 M
-74.70 %
top